Dr Reddy's, Cipla, Aurobindo units recall products in US market

As per the enforcement report by the US Food and Drug Administration (USFDA), the US-based unit of Dr Reddy's Laboratories is recalling 2,838 ampules of vitamin K deficiency treatment drug Phytonadione Injectable Emulsion. According to the USFDA, Dr Reddy's Laboratories is recalling the affected lot due to "failed stability specifications".

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/C3npBVy
via IFTTT

0 comments:

Post a Comment